Literature DB >> 21983631

Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects.

Gabriella d'Ettorre1, Marco Francone, Massimo Mancone, Giancarlo Ceccarelli, Adriano Ascarelli, Francesco Vullo, Silvia Baroncelli, M Clementina Galluzzo, Carlo Catalano, Stefano Strano, Francesco Fedele, Claudio Mastroianni, Lucia Palmisano, Vincenzo Vullo.   

Abstract

OBJECTIVES: increased incidence of acute coronary events, high rate of abnormal surrogate markers of atherosclerosis and increased amount of coronary calcium have been described in HIV infected population. To expand knowledge on coronary artery disease (CAD) in HIV patients, cardiac CT scan was performed in asymptomatic subjects with low cardiovascular (CV) risk.
METHODS: A cross-sectional study using dual-source CT (MDCT) coronary angiography.was conducted in HIV-infected subjects with the following characteristics: Framingham Risk Score (FRS) ≤10, absence of metabolic syndrome, negative echocardiographic and ECG stress-test. A luminal narrowing exceeding 50% was defined as a clinically significant coronary stenosis. Calcium score was quantified using the Agatston Calcium Score method.
RESULTS: Fifty-five subjects were enrolled. Significant coronary stenoses, requiring coronary angiography, were found in 16/55 (29.1%). At multivariate analysis older age was the only variable independently associated with the presence of significant luminal narrowing (p = 0.011).
CONCLUSIONS: MDCT showed an unexpected, age-associated high rate of significant coronary stenosis in asymptomatic HIV positive subjects with low CV risk. These findings suggest that aggressive screening programs for coronary artery disease may be appropriate in this population; further studies are recommended to assess the appropriateness of MDCT for this purpose.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21983631     DOI: 10.1016/j.jinf.2011.09.007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  14 in total

1.  The hidden risk: Incorporating inflammation and HIV serostatus into coronary artery disease screening.

Authors:  Gregory A Payne; Edgar Turner Overton
Journal:  J Nucl Cardiol       Date:  2016-11-16       Impact factor: 5.952

2.  Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?

Authors:  Denis Mariano-Goulart; Jean-Marc Jacquet; Nicolas Molinari; Aurélie Bourdon; Meriem Benkiran; Mélanie Sainmont; Luc Cornillet; Jean-Christophe Macia; Jacques Reynes; Fayçal Ben Bouallègue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

3.  HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS).

Authors:  T S Metkus; T Brown; M Budoff; L Kingsley; F J Palella; M D Witt; X Li; R T George; L P Jacobson; W S Post
Journal:  HIV Med       Date:  2015-05-13       Impact factor: 3.180

Review 4.  Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV.

Authors:  Stephani C Wang; Gurleen Kaur; Joshua Schulman-Marcus; Scott Purga; Sulagna Mookherjee; Cyndi Miller; Mandeep S Sidhu; Robert S Rosenson
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-26       Impact factor: 3.727

5.  Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.

Authors:  Jonathan A Hudson; Edith D Majonga; Rashida A Ferrand; Pablo Perel; Shirjel R Alam; Anoop S V Shah
Journal:  JAMA       Date:  2022-09-13       Impact factor: 157.335

6.  Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy.

Authors:  Yalçın Hacıoğlu; Mohit Gupta; Tae Young Choi; Richard T George; Christopher R Deible; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Wendy S Post; Matthew J Budoff
Journal:  Anadolu Kardiyol Derg       Date:  2013-01-30

7.  Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients.

Authors:  T S Metkus; J Timpone; D Leaf; M Bidwell Goetz; W S Harris; T T Brown
Journal:  HIV Med       Date:  2013-05-19       Impact factor: 3.180

8.  Taming HIV-related inflammation with physical activity: a matter of timing.

Authors:  Gabriella d'Ettorre; Giancarlo Ceccarelli; Noemi Giustini; Claudio M Mastroianni; Guido Silvestri; Vincenzo Vullo
Journal:  AIDS Res Hum Retroviruses       Date:  2014-09-17       Impact factor: 2.205

Review 9.  Coronary artery disease in patients with human immunodeficiency virus infection.

Authors:  Pratik Mondal; Ahmed Aljizeeri; Gary Small; Saurabh Malhotra; Prakash Harikrishnan; Jacquita S Affandi; Ronny R Buechel; Girish Dwivedi; Mouaz H Al-Mallah; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2020-08-20       Impact factor: 5.952

10.  Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin.

Authors:  Alessandra D'Abramo; Claudia D'Agostino; Alessandra Oliva; Marco Iannetta; Gabriella D'Ettorre; Francesco Vullo; Massimo Mancone; Maria Rosa Ciardi; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  ISRN AIDS       Date:  2013-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.